PARAMETRIC PORTFOLIO ASSOCIATES LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 91 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$3,233,000
+81.4%
198,832
+54.6%
0.00%
+100.0%
Q4 2021$1,782,000
-45.9%
128,643
-43.8%
0.00%
-50.0%
Q3 2021$3,292,000
-5.3%
229,056
+4.1%
0.00%0.0%
Q2 2021$3,478,000
+238.0%
220,014
+117.4%
0.00%
+100.0%
Q1 2021$1,029,000
+63.3%
101,189
+19.7%
0.00%
Q4 2020$630,000
+117.2%
84,534
+0.2%
0.00%
Q3 2020$290,000
-88.8%
84,345
-84.4%
0.00%
-100.0%
Q2 2020$2,583,000
+2509.1%
542,129
+998.1%
0.00%
Q1 2020$99,000
-9.2%
49,368
+56.6%
0.00%
Q4 2019$109,000
-32.7%
31,519
-44.3%
0.00%
Q3 2019$162,000
+157.1%
56,618
+239.9%
0.00%
Q2 2019$63,000
-94.0%
16,655
-87.1%
0.00%
-100.0%
Q1 2019$1,053,000
+12.4%
129,306
+11.4%
0.00%0.0%
Q4 2018$937,000
+1042.7%
116,110
+712.9%
0.00%
Q2 2018$82,000
+34.4%
14,284
+10.9%
0.00%
Q1 2018$61,000
+5.2%
12,877
+9.9%
0.00%
Q4 2017$58,0000.0%11,720
+5.9%
0.00%
Q3 2017$58,000
-60.3%
11,072
-26.0%
0.00%
Q3 2014$146,00014,9600.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
DG Capital Management, LLC 1,186,726$4,076,0002.45%
Sarissa Capital Management LP 4,861,000$16,697,0001.97%
Ghost Tree Capital, LLC 1,950,000$6,698,0001.94%
ORACLE INVESTMENT MANAGEMENT INC 2,525,857$8,676,0001.14%
Eversept Partners, LP 1,143,211$3,926,9300.87%
DAFNA Capital Management LLC 749,051$2,573,0000.84%
KNOTT DAVID M 397,361$1,365,0000.80%
Parkman Healthcare Partners LLC 800,740$2,751,0000.73%
ACUTA CAPITAL PARTNERS, LLC 660,000$2,267,0000.62%
Formidable Asset Management, LLC 578,200$1,949,0000.57%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders